This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays
Well Characterized Biologics & Biological Assays is now part of BioProcess International
September 23-26, 2024Hynes Convention Center in Boston, USA

David Gemmell
MSAT Biomanufacturing Engineer at Merck & Co.
Speaker

Profile

David Gemmell has been working for Merck for over seven years. Based in Glasgow, Scotland, he is employed as a Technical Application Specialist, focusing on downstream purification. Previous roles in Merck involved working within Merck MSAT (Manufacturing Sciences & Technology) departments providing support relating to optimising or troubleshooting downstream unit operations for European customers, relating to both novel and traditional modalities. He also has a significant insight on upstream viral risk mitigation, specifically around pasteurization systems. At University David obtained a BEng (Hons) in Chemical Engineering and an MSc in Advanced Chemical & Process Engineering.

Agenda Sessions

  • mRNA Manufacturing & Purification Strategies

    9:00am